A technology evaluation of the Onyx Frontier drug-eluting stent.


Journal

Expert opinion on drug delivery
ISSN: 1744-7593
Titre abrégé: Expert Opin Drug Deliv
Pays: England
ID NLM: 101228421

Informations de publication

Date de publication:
May 2023
Historique:
medline: 19 6 2023
pubmed: 19 5 2023
entrez: 19 5 2023
Statut: ppublish

Résumé

Onyx Frontier We hereby review the principal design features of Onyx Frontier, highlighting differences and similarities with other currently available drug-eluting stents. In addition, we focus on the refinements of this newest platform as compared with previous ZES versions, including the attributes yielding its exceptional crossing profile and deliverability. The clinical implications related to both its newest and inherited characteristics will be discussed. The nuances of the latest Onyx Frontier, together with the continuous refinement previously witnessed throughout the development of ZES, lead to a latest generation device ideal for a diverse spectrum of clinical and anatomical scenarios. In particular, its peculiarities will be of benefit in the settings often offered by a progressively aging population, such as high bleeding risk patients and complex coronary lesions.

Identifiants

pubmed: 37203200
doi: 10.1080/17425247.2023.2216449
doi:

Substances chimiques

zotarolimus H4GXR80IZE
Cardiovascular Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

689-701

Auteurs

Pier Pasquale Leone (PP)

Division of Cardiology, Montefiore Medical Center, Bronx, NY, USA.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Cardio Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.

Manaf Assafin (M)

Division of Cardiology, Montefiore Medical Center, Bronx, NY, USA.

Andrea Scotti (A)

Division of Cardiology, Montefiore Medical Center, Bronx, NY, USA.

Maday Gonzalez (M)

Division of Cardiology, Montefiore Medical Center, Bronx, NY, USA.

Andrea Mignatti (A)

Division of Cardiology, Montefiore Medical Center, Bronx, NY, USA.

Kathryn Dawson (K)

Division of Cardiology, Montefiore Medical Center, Bronx, NY, USA.

Judah Rauch (J)

Division of Cardiology, Montefiore Medical Center, Bronx, NY, USA.

Asma Khaliq (A)

Division of Cardiology, Montefiore Medical Center, Bronx, NY, USA.

Dimitrios Bliagos (D)

Division of Cardiology, Montefiore Medical Center, Bronx, NY, USA.

Azeem Latib (A)

Division of Cardiology, Montefiore Medical Center, Bronx, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH